Mobilized Peripheral Blood CD34+ Stem Cells, Plerixafor, Frozen
Mobilized Human Peripheral Blood CD34+ Stem Cells are isolated from donors injected with 240μg/kg of Plerixafor® (aka Mozobil) the day before collection. Mobilized CD34+ stem cells are enriched using immunomagnetic anti-CD34 (clone QBEND10) microbeads from mobilized peripheral blood mononuclear cells. Isolated primary cells are characterized by flow cytometry to ensure a highly pure and viable cell population.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies. By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.
Description
Mobilized Human Peripheral Blood CD34+ Stem Cells are isolated from donors injected with 240μg/kg of Plerixafor® (aka Mozobil) the day before collection. Mobilized CD34+ stem cells are enriched using immunomagnetic anti-CD34 (clone QBEND10) microbeads from mobilized peripheral blood mononuclear cells. Isolated primary cells are characterized by flow cytometry to ensure a highly pure and viable cell population.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Additional information
Weight | N/A |
---|---|
Anticoagulant | |
Format | |
Grade | |
Species | |
Cell and Tissue Source | |
Disease State | |
Donor Attributes |
Product Information Sheet
Mobilized Peripheral Blood CD34+ Stem Cells, Plerixafor, Frozen
Material Safety Data Sheet
Mobilized Peripheral Blood CD34+ Stem Cells, Plerixafor, Frozen